top of page

Dr Andrew Humberstone
(BPharm PhD)

Director Clinical Development

2023_Low Res_AH white background CROP_Aravax Headshot_JoanneManaritiPhotography_05.jpg

Andrew Humberstone has over 25 years regulatory and clinical development experience in both small and large pharmaceutical companies including SmithKline Beecham (UK), Allergan (France), Acrux (Australia), Shire (Switzerland). Most recently, before joining Aravax, he was Vice President Clinical Science at ObsEva in Geneva.


Dr Humberstone received his BSc(hons)Pharm. from the University of Manchester and PhD from Monash University

bottom of page